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Abstract
Multiphoton laser tomography (MPT) combined with fluorescence lifetime imaging (FLIM) is a non-invasive imaging
technique, based on the study of fluorescence decay times of naturally occurring fluorescent molecules, enabling a non-
invasive investigation of the skin with subcellular resolution. The aim of this retrospective observational ex vivo study, was to
characterize melanoma both from a morphologic and a quantitative point of view, attaining an improvement in the
diagnostic accuracy with respect to dermoscopy. In the training phase, thirty parameters, comprising both cytological
descriptors and architectural aspects, were identified. The training set included 6 melanomas with a mean Breslow
thickness6S.D. of 0.8960.48 mm. In the test phase, these parameters were blindly evaluated on a test data set consisting of
25 melanomas, 50 nevi and 50 basal cell carcinomas. Melanomas in the test phase comprised 8 in situ lesions and had a
mean thickness6S.D. of 0.7761.2 mm. Moreover, quantitative FLIM data were calculated for special areas of interest.
Melanoma was characterized by the presence of atypical short lifetime cells and architectural disorder, in contrast to nevi
presenting typical cells and a regular histoarchitecture. Sensitivity and specificity values for melanoma diagnosis were 100%
and 98%, respectively, whereas dermoscopy achieved the same sensitivity, but a lower specificity (82%). Mean fluorescence
lifetime values of melanocytic cells did not vary between melanomas and nevi, but significantly differed from those referring
to basal cell carcinoma enabling a differential diagnosis based on quantitative data. Data from prospective preoperative
trials are needed to confirm if MPT/FLIM could increase diagnostic specificity and thus reduce unnecessary surgical
excisions.
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Introduction
Melanoma (MM) is a lethal cancer among skin malignancies,
with an increasing incidence worldwide [1,2]. Despite a high cure
rate for thin melanomas, advanced melanomas have a poor
prognosis. Thus, early identification of melanoma represents a
crucial end point for physicians. To optimize early diagnosis,
instrumental methods have been introduced to support clinical
diagnosis [3–5]. However, with established techniques, diagnostic
accuracy does not reach 100% [6]. Therefore, further technolog-
ical efforts are underway with the aim of facilitating the precocious
recognition of the black cancer.
Multiphoton excited fluorescence imaging (multiphoton tomog-
raphy, MPT) with near-infrared femtosecond-pulsed lasers enables
ex vivo and in vivo non-invasive investigation of the skin with
subcellular resolution (0.5 mm in lateral direction and 1–2 mm in
the axial direction) [7–11]. Due to naturally occurring endogenous
fluorescent bio-molecules such as flavins, NAD(P)H coenzymes,
metal-free porphyrins, components of lipofuscin, melanin, elastin,
collagen and keratin, fluorescence imaging can be performed
without additional contrast agents. Fluorescence light emitted by
organic molecules is not only characterized by its emission
intensity, but also by the shape of the fluorescence emission
spectra [12] and by specific fluorescence decay times [13,14],
which can also be influenced by the metabolic state of the cells
[15,16]. Fluorescence lifetime imaging (FLIM) can be performed
using fast detection electronics [13], and the resulting data is
usually presented using a false-color scale image where color
encodes fluorescence lifetime. Since melanin exhibits a short
fluorescence decay component of around 200 ps [17], FLIM can
be used to distinguish cells containing melanin from keratinocytes
that do not contain melanin and exhibit predominantly NAD(P)H
PLOS ONE | www.plosone.org 1 July 2013 | Volume 8 | Issue 7 | e70682
fluorescence with a longer mean fluorescence lifetime (,0.4–2 ns
depending on protein binding state) [18,19] (Fig. 1). Thus, FLIM is
particularly suited for the study of melanocytic lesions [18,20].
With MPT-FLIM, bidimensional images are acquired and
correspond to optical sectioning parallel to the tissue surface.
Pictures obtained at various depths are generated by sequentially
modifying the depth of the focus plane in the tissue reaching levels
of 200 mm. Thus, only the superficial part of skin tumors can be
studied.
The aim of our study was to identify morphologic descriptors for
melanoma, referring both to cellular features and to architectural
aspects, employing MPT fluorescence intensity and FLIM (MPT/
FLIM descriptors), and to establish a specific terminology for their
assessment. Subsequently, we evaluated the frequency of these
descriptors in 3 different populations comprising melanomas,
melanocytic nevi and basal cell carcinomas (BCCs), to establish
sensitivity and specificity of MPT/FLIM diagnosis. Finally, the
diagnostic accuracy for MM achieved by MPT/FLIM was
compared to that of dermoscopy.
Materials and Methods
Study Design
The study was divided into two parts, a training phase and a test
phase. In the former, FLIM images referring to 6 MMs were
simultaneously evaluated by 3 observers (SS, CD, PF), for the
identification of morphologic descriptors characteristic of MM.
Proposed descriptors were discussed and 30 parameters were
selected after unanimous approval.
In the test phase, the presence/absence of the specified criteria
were blindly evaluated on a test data set, by 3 independent
observers (SS, FA, CM), who also classified the images into those
pertaining to melanoma or "other".
Moreover, the mean fluorescence lifetime inside a region of
interest corresponding to one representative melanin containing
cell of each sample, was calculated on images acquired at an
excitation wavelength of 760 nm on 25 MMs, 50 nevi and
50 BCCs samples.
The local ethics committee (University of Modena and Reggio
Emilia, Modena University Hospital Ethics Committee) granted
approval of the study protocol before the start of the study. The
patients provided their written informed consent.
Patients and Lesions
The training set included 6 melanomas with a mean Breslow
thickness6S.D. of 0.8960.48 mm. In the test phase ex vivo samples
of 25 MMs, 50 nevi and 50 BCCs were considered. MMs, of the
superficial spreading type, included 8 in situ lesions and had a
mean Breslow thickness (6 S.D.) of 0.77 (61.2) mm (thickness
range 0–4.7 mm). No amelanotic and nodular melanomas or
lesions showing histological regression were included, but 3 MMs
showed a nodular component. Nevi were removed surgically
because of equivocal dermoscopic features. BCCs comprised 31
nodular BCCs and 19 superficial BCCs, and one third were
pigmented. In all cases, the clinical diagnosis was confirmed by
conventional histopathological examination.
Instrumentation and Elaboration of the Data
Multiphoton tomography. In this study we used the MPT
DermaInspectH imaging system (Jenlab GmbH, Jena, Germany),
which provides intra tissue scanning with subcellular spatial
resolution (0.5 mm in lateral direction and 1–2 mm in the axial
direction) [8,9,18]. The instrument has been described in detail
elsewhere [19,20].
Fluorescence lifetime imaging. FLIM was implemented in
the DermaInspectH system using a TCSPC module with a
temporal instrument response function of approximately 250 ps
(full-width at half-maximum). Data was collected with time bins
separated by 50 ps. A short pass optical filter (Schott BG39) was
used to protect the detector (PMH 100-1, Becker & Hickl GmbH,
Berlin, Germany) from scattered excitation light. The resulting
spectral detection window was , 340 nm –610 nm.
The FLIM images were calculated using the software
SPCImage (Becker & Hickl GmbH). The raw data was smoothed
using a 5 x 5 kernel (corresponding to binning setting 2 in
SPCImage) and a single exponential decay was fitted at each pixel.
The final image output of the FLIM analysis is a pseudocolor
image where the color scale encodes the fluorescence lifetime and
image brightness encodes the fluorescence intensity. Images were
displayed with a red to blue color scale corresponding to 2
fluorescence lifetime ranges: 0–2000 ps (all figures except Fig. 2c)
and 0–400 ps (Fig. 2c). We note that the fluorescence decay
recorded in a given single pixel can originate from multiple
autofluorescent species that can each have complex multi-
exponential decay profiles. Given the relatively small number of
photons detected in a single pixel, we chose to fit a single
exponential decay model to the data in order to generate an
estimate of the mean fluorescence lifetime in that pixel. While
more complex multi-exponential decay models can provide
additional information, e.g. on relative contributions from
different fluorescent species, the use of a single exponential decay
model is a straightforward approach enabling fluorescence lifetime
contrast to be extracted from the fluorescence decay data.
Image Acquisition and Analysis
Ex vivo samples were placed on a cork disc covered by a
transparent film and a gauze. For the examination of the samples a
drop of water was placed between the skin and the cover glass,
which was then attached to a metal coupling ring by circular
adhesive tape. The metal coupler was magnetically connected to
the MPT system after applying a drop of oil (ImmersolTM 518F,
Carl Zeiss Ltd, Germany). After finding the correct level, the focus
on a specific layer was found by means of the software
JLScan_1100. The imaging depth was first pinpointed to the
upper layer (stratum corneum). Subsequently, two-dimensional,
horizontal images were acquired through optical sectioning
parallel to the tissue surface (i.e., in the x–y plane) with an
interval of 15 mm. Three-dimensional data sets, called z-stacks,
were obtained by sequentially changing the plane of focus (z-level),
thus scanning at different tissue depths to a depth of approximately
200 mm.
One optical section, consisting of 2566256 pixels, was taken
with a scanning time of 25.5 s/frame and an excitation power
between 20 and 45 mW. Excitation wavelengths of 760 nm and
820 nm were applied for the assessment of the lesions.
When imaging in the dermis, autofluorescence signals from both
collagen fibers (SHG signal) and elastin fibers (autofluorescence)
can be generated. Separation of these signals was accomplished by
an optical filter (Semrock, BLP01-405R-25, ,0.04% transmission
at 415 nm) that can be inserted into the beam path and which
excludes the SHG component of the signal when exciting at up to
820 nm. Imaging was accomplished within 30 minutes from
biopsy.
FLIM images produced by SPCImage were analysed using a
custom-written software package to calculate the mean fluores-
cence lifetime values for selected areas of interest such as single
cells on 25 MMs, 50 nevi and 50 BCCs.
Multiphoton Laser Tomography for Melanoma
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Dermoscopy
Dermoscopic diagnosis was performed on 20-fold and 50-fold
magnified images acquired by means of a digital epiluminescence
microscope (FotoFinder, TeachScreen software GmbH, Bad
Birnbach, Germany) by 3 observers experienced in dermoscopy
according to established dermoscopic criteria for MM [22–27].
Figure 1. Multiphoton laser tomography and fluorescence lifetime imaging of healthy skin, melanocytic lesions and basal cell
carcinoma. A and B. Images referring to the same epidermal area (healthy skin of a phototype 4 subject); in A, the multiphoton image, in B, the
corresponding color coded image, enabling the recognition of green large keratinocytes (keratinocytes without pigment, asterisk), large orange
melanin-containing keratinocytes (thick arrow) and small red melanocytes (thin arrow). C, D and E. Melanocytic nevus; C, red-orange cells
corresponding to melanocytes, regular in size and shape in the upper epidermal layers; D, a melanocytic nest, consisting of aggregated orange
melanin containing cells at the dermal-epidermal junction (the arrows indicate the papillae); E, a small melanocytic nest close to the tip of the papilla
(arrow), where red collagen fibers are visible (asterisk). F, basal cell carcinoma; a nest of blue basaloid cells is clearly visible (thick arrow), infiltrating
green normal keratinocytes (thin arrow); asterisks indicate blood vessels.
doi:10.1371/journal.pone.0070682.g001
Multiphoton Laser Tomography for Melanoma
PLOS ONE | www.plosone.org 3 July 2013 | Volume 8 | Issue 7 | e70682
The test data set for dermoscopy comprised the same lesions
studied by MPT/FLIM (25 MMs, 50 nevi and 50 BCCs). Images
were presented in a mixed order to the observers, who evaluated
them blinded to the histopathologic diagnosis and without
knowledge of any clinical data of patients and lesions. For each
lesion, observers were asked to make the diagnosis of MM vs non
MM. In the absence of unanimity, the diagnosis was established
when 2 out of the 3 observers agreed.
Statistics
The frequency of each descriptor in MM, nevi and BCC
samples was computed. Sensitivity and specificity values of single
descriptors and of the MPT/FLIM diagnosis of MM were
evaluated as compared with histopathologic diagnosis. Moreover,
odds ratios (OD) were calculated for each descriptor. The
agreement between ratings made by 3 observers on the diagnosis
and specific patterns of MM (inter-rater reliability) was estimated
using Cohen kappa statistics with 95% confidence intervals.
Finally, mean values and standard deviations of the fluorescence
decay in MM, nevus and BCC cells were calculated and
differences were assessed by means of the t-test. A p-value ,0.05
was considered statistically significant. Statistical examinations
were performed with SPSS 19.0 for Windows (SPSS Inc.,
Chicago, IL, U.S.A.).
Results
All image analysis was performed using pseudocolor FLIM
images produced by the SPCImage software. For each sample, 15
FLIM images were examined. In total, 375 images of MM, 750
images of nevi and 750 images of BCC were considered.
Training Phase
Identification of MPT/FLIM descriptors for melanoma
and choice of the appropriate terminology (Table 1).
Considering 90 images corresponding to 6 MM stacks, 30
descriptors were identified. Keratinocytes, which are not always
recognizable at the surface, are infiltrated by atypical melanocytes.
When displaying images using a 0–2000 ps fluorescence lifetime
range, MM cells exhibit a short fluorescence decay time (red on
false-colour scale); thus, a carpet of red cells appears at the lesion
surface. Based on previous published work [18], we attribute this
short fluorescence lifetime to a high concentration of melanin (with
a dominant short 200 ps decay component) relative to NAD(P)H
(mean fluorescence lifetime ,0.4–2 ns depending on protein
binding state), and this immediately enables the determination of
the melanocytic nature of the lesion (Fig. 2b).
To increase contrast for the distinction of image details, a 0–
400 ps scale can be applied (Fig. 2c). Since in MM the epidermal
architecture is completely disrupted, it is not possible to refer to
epidermal layers for the description of the morphology of MM.
Thus, a description of MPT/FLIM aspects of MM was performed
considering 2 different levels: a superficial level consisting of the
upper 30 mm and an inferior one comprising all the lower layers
(Fig. 3). At the surface, atypical cells appear as large short-lifetime
cells (ASLCs) of different size, with a nucleus with undefined
contours and a non-homogeneous cytoplasm with speckled
melanin (Fig. 3c,d,e). A peripheral cytoplasmic halo is often
observable due to variable lifetime values of different cell areas.
MM cells may show more than one nucleus. Besides large cells,
smaller cells of different size can be seen. They may be irregularly
distributed or may form aggregates. When the epidermal structure
is still partially observable, ASLCs infiltrate the keratinocytes.
When present, dendritic cells are easily recognized by their
ramifications (Fig. 4a). In some cases, long lifetime cell nests
appearing as aggregates of blue-green spindle shaped cells
(probably corresponding to melanocytic cells without melanin)
are observable.
Deeper MM layers show ASLCs smaller in size with respect to
those observable at the surface (Fig. 3f,g). They are pleomorphic,
with variable size and irregular shape and show an irregular
distribution. At this level ASLCs may form aggregates appearing
as sheets or nests and may infiltrate dermal papillae and hair
follicles (Fig. 4b). When shifting the excitation wavelength to 800–
820 nm, to explore the extracellular matrix, collagen fibers are
seldom visible; in the example shown in Fig. 4c, they surround
ASLC nests. When dermal papillae are recognizable, they are
mostly not surrounded by a rim of regularly arranged melanocytes
as in melanocytic nevi [20], show irregular size and shape and are
separated by interpapillary spaces of different thickness (non-edged
papillae). An architectural disorder is generally observable.
Testing Phase
Frequency of MM descriptors (Table 1). The frequency of
MM descriptors in MMs, nevi and BCCs is illustrated in Table 1.
The frequency of MM descriptors for MM ranged between 96%
and 8%. ASLCs in the upper layers were present in 24 out of
25 MMs, and were characterized in most cases by large cells
Figure 2. Multiphoton laser tomography and fluorescence lifetime imaging of melanoma. A, MPT image of upper melanoma layers; B,
FLIM image of the same spot displayed by a 0–2000 ps fluorescence lifetime range showing that all cells are melanocytic; C, 0–400 scale, employed to
increase contrast for the distinction of cellular details, such as the cytoplasmic halo and the speckling. Dots indicate nuclei with undefined contours;
arrows indicate polinucleated cells; asterisks indicate cytoplasmic halo, and triangles speckled melanin. FLIM values do not change, they are only
displayed in a different way.
doi:10.1371/journal.pone.0070682.g002
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Figure 3. Fluorescence lifetime imaging of melanoma at
different depth. A, dermoscopic images and stacks of 3 melanomas;
B, typical dermoscopic features; C, and D, upper melanoma layers,
characterized by orange atypical large short-lifetime cells (ASLCs)
irregularly distributed or forming aggregates. Cells are pleomorphic and
show a nucleus with undefined contours and a non-homogeneous
cytoplasm with speckled melanin. A peripheral cytoplasmic halo is
observable in some cells (triangles), some of which are polinucleated
(dots). E, F and G, deeper MM layers with ASLCs variable in size, shape
and distribution forming aggregates and infiltrating papillae (thick
arrows) and hair follicles (thin arrows).
doi:10.1371/journal.pone.0070682.g003
Multiphoton Laser Tomography for Melanoma
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(88%), different in size (88%) with a nucleus with undefined
contours (92%) and speckled melanin (88%). One third of these
cells showed a cytoplasm with a halo; 76% were polinucleated,
and 92% were irregularly distributed. Aggregates of these atypical
cells were found in 19 MMs, whereas in 15 MMs ASLCs
infiltrating epidermal cells were recognizable at the surface. In
nevi, keratinocytes were always present at the surface, and in 18%
of the cases only, some atypical cells were visible. However, these
never showed more than one nucleus and a cytoplasmic halo.
Sporadic short lifetime cells, large and different in size, were also
visible in 3 pigmented BCCs, but they never showed other features
characterizing ASLCs in melanocytic lesions. We were able to
detect dendritic cells in 5 MMs, 2 nevi and one BCC. The
characteristics of these cells did not differ between the 3
populations.
Lower MM layers were characterized by ASLCs, different in
size, in 88% of the cases. These frequently showed nuclei of
different size, were irregular in shape and irregularly distributed,
forming aggregates (72%), sheets (84%) or nests (32%). Invasion of
the papillae was visible in half of the cases, whereas nests
surrounded by fibers or single ASLCs intermingled with fibers
were observable in approximately 10% of the cases. Short lifetime
cells, different in size or with an irregular distribution were found
in 2 nevi.
With regard to structural aspects, an architectural disorder was
observed in 24 MMs and in 2 nevi. Non edged papillae were
observed in 40% of MMs and in 10% of nevi. These were always
associated to edged papillae in nevi, whereas in MMs, edged
papillae were recognizable only in 3 cases. The x square test,
calculated on the populations of MMs vs nevi, was significant for
all descriptors.
Sensitivity and specificity for MM diagnosis and for
single MM descriptors. The classification of a lesion as MM
was made based on the presence of ASLCs in the upper layers and
architectural disorder. This approach correctly identified 100% of
the cases of MM and produced one false positive in nevi (Table 1).
Sensitivity and specificity for single MM descriptors were high for
most descriptors.
Interobserver agreement (Table 1). The results of the
kappa statistics analysis showed a good reliability of all criteria
with kappa values ranging from 0.468 to 1.000.
Odds ratios (Table 1). Among the descriptors, the ones with
the highest probability to identify a MM (OR = 1176) were
"ASLCs irregular distribution upper layers" and "ASLCs different
size lower layers", followed by "ASLCs lower layers" and
"architectural disorder" (OR = 576).
Mean fluorescence lifetime values (Table 2). Fluorescence
lifetime values obtained from a single exponential decay fit to the
data (+ s.d.), calculated on 3 representative cells on both upper and
lower layers of 25 MMs were 347+159 ps and 338+170 ps,
respectively. No difference was observed between these values
and those referring to nevi (362+121 ps), whereas for BCC the
fluorescence lifetime value was significantly higher
(1395+130 ps).’’
Dermoscopy. All MMs were correctly diagnosed by dermo-
scopy (sensitivity = 100%), whereas 9 nevi were diagnosed as MM
(specificity = 82%).
Discussion
Instrument-based methods have been introduced as a support to
clinical diagnosis for early detection of MM and improvement of
its prognosis. Dermoscopy is nowadays widely employed in clinical
practice [28]. Recently, reflectance confocal microscopy (RCM)
has been introduced in selected settings as an imaging method that
allows real-time skin examination at a subcellular resolution,
further improving melanoma diagnosis [29,30]. As a technique
with a resolution superior to that of RCM, MPT constitutes one of
the most promising and fastest developing technologies in the field
of optically sectioned clinical imaging. It is based on the emission
of naturally occurring endogenous fluorescent bio-molecules.
These, however, often present overlapping fluorescence spectra,
Figure 4. Fluorescence lifetime imaging: different features of melanoma. A, dendritic cells in upper melanoma layers (asterisks); B,
melanoma cells infiltrating a non edged papilla (arrows); C, red collagen fibers surrounding ASLC nests (arrows).
doi:10.1371/journal.pone.0070682.g004
Table 2. Fluorescence decay value of melanomas, melanocytic nevi and basal cell carcinomas.
Fluorescence decay value MMs mean and s.d. Nevi mean and s.d. BCCs mean and s.d.
Upper layers 347.236158.82 362.066120.71 1395.256129.82
Lower layers 338.376169.75 – –
doi:10.1371/journal.pone.0070682.t002
Multiphoton Laser Tomography for Melanoma
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thus hampering the distinction between different fluorophores or
metabolic states.
Melanins are the main pigments of both constitutive and light-
induced human skin color. They are synthesized in specialized
organelles and then transferred to surrounding keratinocytes.
Melanin content is generally increased in benign and malignant
melanocytic lesions and may represent a clue to their recognition.
Melanins differ from other skin fluorophores owing to their short
fluorescence decay component. Dimitrow et al. investigated
procedures of spectral FLIM on 46 melanocytic lesions, and
observed remarkable differences in lifetime behaviour between
keratinocytes and melanocytes [18]. Fluorescence lifetime distri-
bution varied according to the intracellular amount of melanin.
However, FLIM on single data points seemed to be unsuitable for
a classification of benign versus malign melanocytic skin lesions.
Thus, only the combination of morphologic features with lifetime
behavior studies employing MPT associated to FLIM provides
clues to cell differentiation.
Distinct morphological differences between MM and melano-
cytic nevi were detected in a study employing only MPT
fluorescence intensity imaging by the same group considering 83
melanocytic skin lesions including 26 MMs [21]. Six characteristic
features of MM were described, and, among these, architectural
disarray of the epidermis, poorly defined keratinocyte cell borders
and the presence of pleomorphic or dendritic cells were of prime
importance for the diagnosis.
In order to assess the potential use of the combination of MPT
with an improved FLIM technique in MM diagnosis, we
performed an observer-blinded study on melanocytic skin lesions
to identify robust MPT/FLIM descriptors enabling diagnostic
sensitivity, specificity, and reliability values, high enough to
guarantee clinical applicability and provide results better than
those obtained by a conventional imaging technique, i.e.
dermoscopy.
MM cells on the surface of the lesion are recognizable at the first
glance: starting the scanning of a malignant melanocytic lesion,
these pleomorphic atypical cells entirely occupy the upper sheets
and are red colored (short lifetime) when employing a 0–2000 ps
color scale. ASLCs appear as single cells, irregularly distributed or
aggregated, with a distribution similar to that of ascending
melanocytes in histopathological sections.
Contrary to what was observed by Dimitrow et al. [21], a
residual epidermal structure could be recognized in a minority of
MM cases, in contrast to nevi where epidermal structures were
always distinguishable [21]. These observations reflect the classic
cytological changes detected in histopathologic sections of
melanoma, including cellular atypia and pleomorphism, asymme-
try of cytological details, and pagetoid spread, i.e. melanocytes
scattered in the epidermis and in the follicular epithelium [31].
Our morphological data are also in line with those obtained by
RCM, where highly diagnostic features associated with malignan-
cy are the partial or total loss of the honeycomb epidermal pattern
and the pagetoid spread of roundish or dendritic cells [29,30]. By
MPT/FLIM, in lower MM layers, atypical cells are smaller and
may form aggregates, sheets or nests. At this level the architecture
is completely disarranged and papillae lacking a border of well-
arranged cells are invaded by atypical melanocytes. These aspects
correspond to the presence of atypical cells in the basal layer and
irregular or non-edged papillae by confocal [29,30]. Conversely, a
monomorphic and regular histoarchitecture was observed in nevi.
In benign lesions, melanocytes were typically visualized as small
cells, and nevus cell nests were found at the dermoepidermal
junction. Dendritic cells, representing a major diagnostic criterion
for MM diagnosis according to Dimitrow et al., were observable
only in one fifth of MM cases and showed the same morphology of
those observed in nevi and BCCs. Short lifetime cells, variable in
size, were also found in 6% of BCC cases. However, these cells
never showed more than one nucleus, a nucleus with undefined
contours or a non-homogeneous speckled cytoplasm, like in MMs;
they also did not form aggregates and were regularly distributed.
BCCs showed the typical structure characterized by elongated
cells with double alignment, nests surrounded by fibers and
phantom islands [32–34]. Moreover, the corresponding pseudo-
color fluorescence lifetime images displayed typical blue colored
(longer lifetime) cells with a mean lifetime of 1400 ps that were
readily distinguishable from red-coloured (shorter lifetime) cells
containing melanin. In previous studies fluorescence lifetimes of
healthy epidermal cells in young subjects calculated by our group
were around 1100 ps for upper epidermal layers and 900 ps for
lower ones, corresponding to the green color [19]. In the
epidermis of elderly subjects, keratinocytes show a shift in
fluorescence decay times towards higher values with respect to
young epidermal cells (blue-green) [19].
Fluorescence lifetime depends not only on the fluorophore itself,
but also on the interaction with the local environment [35]. Thus,
changes in fluorescence lifetime with cancerization can be due
both to alterations of cell proliferation and metabolic pathways
and to tissue vascularisation and oxygen supply [36,37].
Similarly to previous published studies [18], our data did not
reveal any difference between mean fluorescence lifetime values of
melanocytic cells in nevi and those in MMs. It has been shown
that, whereas keratinocyte lifetime values correspond to NAD(P)H
[12,38,39], melanocyte ones match with the endogenous fluor-
ophore melanin [17,18]. In the process of malignant transforma-
tion of melanocytic lesions, an increase of the ratio of pheomelanin
to eumelanin has been reported [40], which has been linked to an
increase in fluorescence emission in MM in the red region of the
fluorescence emission spectrum [41–42]. However, this shift in
emission spectrum apparently does not influence the fluorescence
decay time, which our results show are similar in malignant and
benign melanocytic cells. Thus, when employing our MPT/FLIM
instrument, the differentiation between keratinocytic and melano-
cytic skin tumors can be achieved immediately on the basis of
fluorescence decay data, whereas a diagnosis of malignant
melanocytic lesion has to be based also on morphologic
observations.
Most MPT/FLIM descriptors identified in this study showed
high sensitivity and specificity values. Moreover, a sensitivity of
100% and a specificity of 98% were reached for the diagnosis of
MM. These values were higher than those reported by Dimitrow
et al., which were based on a reduced number of parameters,
attaining an overall sensitivity of 84% and an overall specificity of
76%. Moreover, a comparison between the diagnostic capability
of MPT/FLIM and that of dermoscopy, which at present
represents the established diagnostic technique for MM, was
performed for the first time in this study.
Although the penetration depth of MPT is at present limited to
200 mm, making the evaluation of MM thickness impossible, the
MPT/FLIM technique holds great promise for in vivo diagnosis of
melanoma, enabling a diagnostic accuracy higher than that
achieved by dermoscopy. The nevi imaged in this study had been
removed surgically because of equivocal dermoscopic aspects and
were difficult to diagnose even by an experienced dermoscopist.
Thus, MPT/FLIM used in a preoperative phase would have
increased diagnostic specificity and reduced unnecessary surgical
excisions.
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